CHRONIC MEDIAN EMINENCE LESIONS AND OVARIECTOMY: EFFECTS ON FOLLICLE-STIMULATING HORMONE SECRETION IN THE RAT

1971 ◽  
Vol 51 (4) ◽  
pp. 665-674 ◽  
Author(s):  
E. B. CRAMER ◽  
R. E. TRAUM ◽  
S. A. D'ANGELO

SUMMARY Pituitary and serum follicle-stimulating hormone (FSH) concentrations were determined by the Steelman—Pohley ovarian augmentation bioassay method in normal adult rats and in rats subjected to ovariectomy and/or electrolytic lesioning of the tuberal hypothalamus 10, 30 or 90 days previously. Ovariectomy resulted in a rapid, significant increase in FSH concentration of the adenohypophysis. Pituitary FSH concentrations were increased sixfold 10 and 30 days after ovariectomy and by 90 days were increased by 700%. (Hormone stores in the adenohypophysis increased correspondingly.) Serum FSH levels in ovariectomized rats also increased but at a slower rate. Ten days after ovariectomy, serum FSH levels were still normal. Thirty and ninety days postoperatively, serum FSH titres were doubled and quintupled, respectively. Chronic median eminence lesions eventually caused obesity, a marked atrophy of the reproductive system and significant increase in the FSH concentration of the adenohypophysis. Follicle-stimulating hormone was not detected in the sera of rats with short-term lesions but serum hormone levels were in the normal range 30 and 90 days after the lesions were made. Complete destruction of the median eminence in ovariectomized rats was associated with further increase in pituitary FSH concentration and content. Ninety days after simultaneous lesioning and ovariectomy, FSH concentration of the adenohypophysis was almost twice that of the ovariectomized control and the hormone content was about 14 times that in the normal pituitary. In contrast, the raised FSH serum levels observed after long-term ovariectomy were significantly reduced (50%). It is concluded that chronic median eminence lesions which induce obesity and ovarian atrophy in rats differentially affect synthesis and release of FSH by the adenohypophysis.

2008 ◽  
Vol 20 (9) ◽  
pp. 36
Author(s):  
S. M. Ruwanpura ◽  
P. G. Stanton ◽  
D. M. Robertson ◽  
R. I. McLachlan ◽  
Y. Makanji ◽  
...  

Follicle stimulating hormone (FSH) in short-term rat studies supports spermatogenesis at multiple levels, notably spermatogonial development. The role of FSH in supporting full spermatogenesis in rats is still in question as long-term studies have not been possible due the development of neutralising antibodies to heterologous FSH preparations. This study sought to assess the effects of a homologous recombinant rat FSH (rr-FSH) preparation on the long-term restoration of spermatogenesis. Adult rats were GnRH-immunised (GnRH-im) for 12 weeks then, administered an anti-androgen; flutamide (flut), alone or together with rr-FSH (8µg/rat/daily) for 56 days (1 spermatogenic cycle). Germ and Sertoli cell numbers were quantified using an optical disector stereological method. Testis weight, serum FSH and inhibin B and Sertoli cell nuclear volume were significantly reduced to 15%, 13%, 25% and 57% of controls respectively, following GnRH-im+flut treatment. GnRH-im+flut treatment reduced A/I spermatogonial, type B spermatogonial+preleptotene, leptotene+zygotene and early pachytene spermatocyte numbers to 28%, 68%, 50% and 19% (P < 0.001) of controls respectively, with later germ cells rarely observed. After FSH treatment, no significant affect on testis weight, serum FSH and inhibin B or Sertoli cell number were observed. However, rr-FSH treatment significantly increased numbers of A/I spermatogonia, leptotene+zygotene and early pachytene spermatocytes from 28 = >42%, 50 = >69% and 19 = >27% of controls, respectively, while no differences were observed in later germ cell types. rr-FSH also increased (P < 0.05) the volume of Sertoli cell nuclei from 57 = >66% of control. In conclusion, FSH is unable to support full rat spermatogenesis; however, FSH can partially support germ cells notably spermatogonia through to early pachytene spermatocytes, despite the absence of androgenic support.


1976 ◽  
Vol 56 (3) ◽  
pp. 497-504 ◽  
Author(s):  
L. M. SANFORD ◽  
B. E. HOWLAND ◽  
C. FAIMAN ◽  
W. M. PALMER

Blood serum levels of follicle-stimulating hormone (FSH) were observed in rams at various times throughout the year, during a period of intense mating and following treatment with gonadotropin-releasing hormone (Gn–RH). The level of FSH in peripheral blood of two mature rams sampled at 20-min intervals for 24 h in August and January was relatively stable compared to the level of luteinizing hormone (LH). The small elevations in FSH (usually < 50% of baseline values) which were noted did not coincide with or closely follow LH releases. FSH levels were significantly (P < 0.01) lower in both animals in January than in August. These two rams were allowed to mate estrual ewes for a 24-h period in January during which time blood samples were collected as in the non-mating period. Mating activity during the first 12 h was associated with larger elevations and a significantly (P < 0.01) higher mean level of FSH in both animals, in contrast to the comparable non-mating period. Six ram lambs sampled at 2- to 3-wk intervals from May through December exhibited significantly (P < 0.05) higher FSH levels in July and August compared to the other months. No appreciable change in FSH was noted in two additional mature rams when treated with synthetic Gn–RH (10 μg given i.v.) six times over a 9-h period, although marked increases in LH and testosterone occurred.


Animals ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. 1134
Author(s):  
Hao-Qi Wang ◽  
Wei-Di Zhang ◽  
Bao Yuan ◽  
Jia-Bao Zhang

Mammalian reproduction is mainly driven and regulated by the hypothalamic-pituitary-gonadal (HPG) axis. Follicle-stimulating hormone (FSH), which is synthesized and secreted by the anterior pituitary gland, is a key regulator that ultimately affects animal fertility. As a dimeric glycoprotein hormone, the biological specificity of FSH is mainly determined by the β subunit. As research techniques are being continuously innovated, studies are exploring the underlying molecular mechanism regulating the secretion of mammalian FSH. This article will review the current knowledge on the molecular mechanisms and signaling pathways systematically regulating FSH synthesis and will present the latest hypothesis about the nuclear cross-talk among the various endocrine-induced pathways for transcriptional regulation of the FSH β subunit. This article will provide novel ideas and potential targets for the improved use of FSH in livestock breeding and therapeutic development.


Life Sciences ◽  
1985 ◽  
Vol 36 (9) ◽  
pp. 889-899 ◽  
Author(s):  
Henry M. Jones ◽  
Constance L. Wood ◽  
Michael E. Rush

Sign in / Sign up

Export Citation Format

Share Document